Between 500 and 1,000 experts will gather to discuss future directions in research.
Chicago, Ill. (PRWEB) April 25, 2014
Bringing together key individuals and representatives from leading laboratories and centers working with renal cell carcinoma, the Ninth European International Kidney Cancer Symposium, sponsored by the Kidney Cancer Association (KCA) seeks to provide a forum for the exchange of ideas and information that will continue to frame directions for future research and treatment.
“This is the KCA’s ninth European symposium,” says Carrie Konosky, KCA vice president for public affairs, “and we hope to build on the value of gathering experts from throughout the EU and beyond to help unlock the secrets of this rare and deadly cancer, so that patients can live longer.”
KCA president Bill Bro adds, “This annual meeting is supported by grants from major international pharmaceutical companies. Without this generous financial support, it would not be possible for our small charity to sponsor an event of this size. Between 500 and 1,000 experts will gather to discuss future directions in research and best practices for the treatment of patients.”
The Ninth European International Kidney Cancer Symposium takes place April 25 and 26 at The Convention Centre Dublin. Registration is available both online and at the Convention Centre.
KCA was founded in 1990 by a small group of patients, including Eugene P. Schonfeld, Ph.D., and medical doctors in Chicago, Illinois. It is a nonprofit charity incorporated in the State of Illinois. It has also been designated as a tax exempt organization under Section 501(c)(3) of the U.S. Internal Revenue Service code. Donations to the Association are tax deductible in the United States of America.